Ingalfarma announces the recent publication of its Multicenter, Phase 2, Clinical Trial, for the Evaluation of the Efficacy and Safety of Dentoxol® in the prevention of oral mucositis in head and neck cancer patients in the international journal Supportive Care in Cancer.

«It has been very gratifying and enriching to have achieved this milestone for Ingalfarma and we are truly proud that 100% Chilean research and science will go out to the world once again to demonstrate the quality of our scientists and entrepreneurs.»

Comparte esta noticia

Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on pinterest
Share on whatsapp
Share on email